Please login to the form below

Not currently logged in
Email:
Password:

Health Economics

This page shows the latest Health Economics news and features for those working in and with pharma, biotech and healthcare.

OPEN Health expands global footprint with Pharmerit International integration

OPEN Health expands global footprint with Pharmerit International integration

Global health comms and market access group now has presence in six countries. ... Pharmerit International is an expert in health economics and outcomes research (HEOR), and the integration of the company into the OPEN Health group establishes a new

Latest news

More from news
Approximately 1 fully matching, plus 106 partially matching documents found.

Latest Intelligence

  • The mission matters The mission matters

    As a global industry, we do this via about 200 countries, each of which has differing health systems, payer environments and regulatory schemes. ... economics. As Deborah Dunsire, CEO of Lundbeck, put it, our industry demands a very high concentration of

  • Gene therapy market access Q&A Gene therapy market access Q&A

    Jesper Jorgensen, Health Economics and Market Access Manager, Cell and Gene Therapy Catapult. ... and the role of the Health Economics and Market Access function is to provide expertise around commercialisation and market access issues.

  • The Orkambi blame game The Orkambi blame game

    As with the US inquiry, the committee of MPs covered a broad range of topics – some questions trying to get to the nitty-gritty of health economics and NICE procedure to ... The health select committee has yet to complete its inquiry, but will produce

  • Launch trends 2019 Launch trends 2019

    Turn the page for more on key trends in pharma launches from Syneos Health. ... Successful manufacturers start planning their additional evidence early in clinical development, including health economics endpoints in their phase 2 and 3 clinical trials.

  • Relearning launch: Four key dynamics for pharma launches in 2019 Relearning launch: Four key dynamics for pharma launches in 2019

    Syneos Health examines some of the key trends shaping industry launches in 2019 and beyond. ... Innovators are increasingly incorporating these health economics endpoints into phase 2 trials, and throughout phase 3 and real-world data collection.

More from intelligence
Approximately 0 fully matching, plus 35 partially matching documents found.

Latest appointments

  • Vintura appoints Lieven Annemans as an associate partner Vintura appoints Lieven Annemans as an associate partner

    He will advise the consultancy's clients on market access issues. Healthcare and life sciences consultancy firm Vintura has appointed health-economics professor Lieven Annemans as an associate partner after previously ... Bas Amesz, partner at Vintura,

  • VCLS appoints Carole Jones to senior market access role VCLS appoints Carole Jones to senior market access role

    her focus on expanding the company’s market access capabilities, spanning payer strategy, health economics and outcomes research (HEOR), health technology assessment (HTA) and communications support. ... The combination of world class regulatory and

  • Astellas appoints new senior VP Astellas appoints new senior VP

    Dodson has previously led the alignment of medical affairs practices, policies and standards at Astellas, and she has taken on projects such as expanding the Health Economics and Outcomes Research function,

  • McCann Health expands consulting team McCann Health expands consulting team

    Previously serving Healthcare Management Solutions as its senior director and project leader for health economics, global reimbursement and healthcare policy, Goodman’s expertise lies in public healthcare, economics and healthcare policy.

  • Takeda UK & Ireland appoints market access director Takeda UK & Ireland appoints market access director

    Takeda UK &Ireland has appointed Peter Wheatley Price as market access director, succeeding Ross Selby who moves to head the firm's new US-based global pricing, market access and health ... Prior to this, Wheatley Price was associate director of health

More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 38 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare-focused, award-winning video production company which operates in the US and Europe. We create engaging visual...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics